Cynomolgus IL1R2 / IL1RB Protein (Fc Tag)
IL1R2
- 100ug (NPP4433) Please inquiry
| Catalog Number | P90120-C02H |
|---|---|
| Organism Species | Cynomolgus |
| Host | Human Cells |
| Synonyms | IL1R2 |
| Molecular Weight | The recombinant cynomolgus IL1R2 is a disulfide-linked homodimer. The reduced monomer comprises 571 amino acids and has a calculated molecular mass of 64.7 KDa.The apparent molecular mass of the protein is approximately 75-89 KDa respectively in SDS-PAGE. |
| predicted N | Phe 14 |
| SDS-PAGE |  |
| Purity | > 90 % as determined by SDS-PAGE |
| Protein Construction | A DNA sequence encoding the cynomolgus IL1R2 (Q8HXR9) (Met1-Glu343) was expressed, fused with the Fc region of human IgG1 at the C-terminus. |
| Bio-activity | Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus IL1R2-Fc at 10 μg/ml (100 μl/well) can bind biotinylated human IL1B-His (P10139-H07E), The EC50 of biotinylated human IL1B-His (P10139-H07E) is 11.8-27.4 ng/ml. |
| Research Area | Cancer |Cancer immunology |Cytokine & Receptor |Interleukin & Receptor |IL-1 family & Receptor |IL-1 Family Receptor | |
| Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
| Background | Interleukin 1 receptor, type II (IL1R2) also known as CD121b (Cluster of Differentiation 121b) is a cytokine receptor that belongs to the interleukin-1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I (IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. The pleiotropic cytokine IL1 is produced to regulate development and maintenance of the inflammatory responses, and binds to specific plasma membrane receptors on cells. Two distinct types of IL1 receptors which are able to bind IL1 specifically have been identified, designated as IL1RI (IL1RA) and IL1RII (IL1RB). IL1R1 contributes to IL-1 signaling, whereas the IL-1R2/CD121b has no signaling property and acts as a decoy for IL-1. IL-1R2/CD121b structurally consisting of a ligand binding portion comprised of three Ig-like domains, a single transmembrane region, and a short cytoplasmic domain, is expressed in a variety of cell types including B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Interleukin 4 (IL4) is reported to antagonize the activity of interleukin 1 by inducing the expression and release of this cytokine. |
| Reference |